Skip to main content

Animations

MJFF Publications

6501 - 6510 of 9145 Results
Title
Year
  • Year
  • 2020
  • 2024
  • 2019
  • 2013
  • 2020
  • 2014
  • 2024
  • 2019
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28354
    Citation Count: 6
  • Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    2024
    Summary Details
    RESTRICTED
    Title: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.4c00602
    Citation Count: 2
  • Driving genotype treatment options down the right path(way)
    2019
    Summary Details
    RESTRICTED
    Title: Driving genotype treatment options down the right path(way)
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27893
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.12483
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Synthesis and characterization of high affinity fluorogenic α-synuclein probes
    Journal Name: Chemical Communications
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1039/c9cc09849f
    Citation Count: 37
  • Resistance of naturally secreted α‐synuclein to proteolysis
    2014
    Summary Details
    RESTRICTED
    Title: Resistance of naturally secreted α‐synuclein to proteolysis
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.13-245852
    Citation Count: 18
  • A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)
    2024
    Summary Details
    RESTRICTED
    Title: A deep 1-D CNN learning approach with data augmentation for classification of Parkinson’s disease and scans without evidence of dopamine deficit (SWEDD)
    Journal Name: Biomedical Signal Processing and Control
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bspc.2024.106008
    Citation Count: 14
  • How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trial
    2019
    Summary Details
    RESTRICTED
    Title: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Disease progression models for dominantly-inherited Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy089
    Citation Count: 3
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 104
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.